Exact Mass: 416.1282

Exact Mass Matches: 416.1282

Found 99 metabolites which its exact mass value is equals to given mass value 416.1282, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in alcoholic beverages. 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is isolated from Filipendula ulmaria (meadowsweet). Isolated from Filipendula ulmaria (meadowsweet). 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in tea and alcoholic beverages.

Iophendylate

Ethyl 10-(2-iodophenyl)undecanoic acid

C19H29IO2 (416.1212)

Iophendylate is a mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization. Iophendylate is a myelographic oil-ester (U.S. Patent 2,348,231). Iophendylate, which was never shown to be safe, was initially introduced for use in small amounts (1-2cc) for locating spinal tumors. It next appeared on the world scene for high volume (12-15cc), routine use, in diagnosing disc herniations. A number of clinicians have published on the dangers of oil myelography. In 1942 Van Wagenen (a neurosurgical colleague of Warrens, at the University of Rochester) identified Iophendylate as causing chemical meningitis in 30 patients where space-displacing masses within the spinal canal were suspected.

(R)-3-[3-(4-Fluorophenylsulphonylamino)-1,2,3,4-tetrahydrocarbazol-9-yl]propionic acid

C21H21FN2O4S (416.1206)

1-(2-Chloro-4-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-propylurea

N-(2-Chloro-4-((6,7-dimethoxy-4-quinazolinyl)oxy)phenyl)-n-propylurea

C20H21ClN4O4 (416.1251)

alpinoside

C18H24O11 (416.1319)

O-Acetylgeniposidic acid

10-O-Acetylgeniposidic acid

C18H24O11 (416.1319)

Regaloside C

[(2S)-2-Hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

Regaloside C is a natural product found in Lilium henryi, Lilium brownii, and other organisms with data available. Regaloside C is a glycerol glucoside isolated from the bulbs of?Lilium genus with anti-inflammatory activities. Regaloside C has cardiomyocyte protective activity by protecting the mitochondria in H2O2-induced heart H9C2 cells[1].

N,N-diformyldityrosine

C20H20N2O8 (416.122)

4-[O-alpha-apiofuranosyl-(1->2)-beta-D-glucopyranosyloxy]benzaldehyde

C18H24O11 (416.1319)

15-O-deacetylrhaposerin|cebellin J

C19H25ClO8 (416.1238)

regaloside L

C18H24O11 (416.1319)

4-O-(3,4-Dihydroxycinnamoyl)-beta-D-(2R)-1-O-Glucopyranosylglycerol

C18H24O11 (416.1319)

5a,6-Dihydro-3-(1H-indol-3-yl)-1,4-dimethoxy-10bH-benzofuro[2,3-b]indole-2,10b-diol

C24H20N2O5 (416.1372)

1-O-beta-D-(3-caffeoyl)glucopyranosylglycerol

C18H24O11 (416.1319)

vernchinilide C

C19H25ClO8 (416.1238)

Interruptin C

C25H20O6 (416.126)

C18H24O11

C18H24O11 (416.1319)

1-O-beta-D-(6-caffeoyl)glycopyranosylglycerol

C18H24O11 (416.1319)

beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside

C18H24O11 (416.1319)

Regaloside K

C18H24O11 (416.1319)

[(2S)-3-hydroxy-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate is a natural product found in Lilium mackliniae with data available.

(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]chrysin

C25H20O6 (416.126)

(3Z)-6,7-dihydroxy-4-methoxy-3-(phenylmethylidene)-5-(3-phenylpropanoyl)-1-benzofuran-2(3H)-one|bractelactone

C25H20O6 (416.126)

(R)-3-[3-(4-Fluorophenylsulphonylamino)-1,2,3,4-tetrahydrocarbazol- 9-yl]propionic acid

C21H21FN2O4S (416.1206)

tm30089

C21H21FN2O4S (416.1206)

Zuclopenthixol sulfoxide

C22H25ClN2O2S (416.1325)

Iophendylate

C19H29IO2 (416.1212)

CAY10471

(+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid

C21H21FN2O4S (416.1206)

Ramatroban

3R-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid

C21H21FN2O4S (416.1206)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Spiraein (filipendula)

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

2-(Methylthio)-4-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

2-Methylthio-5-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

KRN-633

VEGF receptor tyrosine kinase inhibitor III

C20H21ClN4O4 (416.1251)

Bromerguride

C20H25BrN4O (416.1212)

MK-7246-D3

C21H21FN2O4S (416.1206)

Phosphonicacid, [(phenylamino)-4-pyridinylmethyl]-, diphenyl ester (9CI)

C24H21N2O3P (416.129)

3-[3-[(4-Fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid

C21H21FN2O4S (416.1206)

5-(Benzenesulfonyl)-4-(2,6-dimethylphenoxy)-2-phenylpyrimidine

C24H20N2O3S (416.1195)

2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide

C23H20N4O2S (416.1307)

9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione

C24H20N2O5 (416.1372)

N-(5-adenylyl)morpholine

C14H21N6O7P (416.1209)

An organic phosphoramidate obtained by formal condensation of the phosphate group of AMP with the amino group of L-morpholine.

[(4S,5R,6S,8S,10R)-10-[(S)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

[(4S,5R,6S,8S,10R)-10-[(R)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

4-(6-methoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine

C19H15F3N6O2 (416.1209)

2-(1,3-benzodioxol-5-ylmethyl)-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-3H-isoindol-1-one

C24H20N2O5 (416.1372)

N-(1-isoquinolinyl)-4-[3-(trifluoromethyl)phenyl]-1-piperazinecarbothioamide

C21H19F3N4S (416.1282)

3-[[4-(2-Benzofuranyl)-2-thiazolyl]methyl]-2-[(dimethylamino)methyl]-4-quinazolinone

C23H20N4O2S (416.1307)

12-oxo-N-(4-phenyl-2-thiazolyl)-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazoline-3-carboxamide

C23H20N4O2S (416.1307)

Succinic acid, 2,2,3,3,4,4,5,5-octafluoropentyl 2-methylpent-3-yl ester

C15H20F8O4 (416.1234)

N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-methylpentanamide

C20H24N4O2S2 (416.1341)

Dipyrromethane cofactor(4-)

C20H20N2O8-4 (416.122)

2-[(3S,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

4-(3-Methoxybenzoyl)-5-(4-methoxyphenyl)-1-pyridin-2-ylpyrrolidine-2,3-dione

C24H20N2O5 (416.1372)

[(S)-3-[[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-2-hydroxypropyl]beta-D-glucopyranoside

C18H24O11 (416.1319)

ethyl 10-(2-iodophenyl)undecanoate

C19H29IO2 (416.1212)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

C18H24O11 (416.1319)

(8r,9r)-8-benzyl-5,8,9-trihydroxy-6-methyl-4-phenyl-9h-furo[2,3-h]chromen-2-one

C25H20O6 (416.126)

(2r)-1-hydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

1-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

(1r,9r)-5-(1h-indol-3-yl)-3,6-dimethoxy-8-oxa-10-azatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]hexadeca-2,4,6,11,13,15-hexaene-1,4-diol

C24H20N2O5 (416.1372)

10-O-acetylgeniposidic acid

C18H24O11 (416.1319)

{"Ingredient_id": "HBIN000178","Ingredient_name": "10-O-acetylgeniposidic acid","Alias": "NA","Ingredient_formula": "C18H24O11","Ingredient_Smile": "CC(=O)OCC1=CCC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "416.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39936","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101996850","DrugBank_id": "NA"}